Cargando…
Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions
BACKGROUND: Although mainly causing a respiratory syndrome, numerous neurological symptoms have been identified following of SARS-CoV-2 infection. However, how the virus affects the brain and how the mutations carried by the different variants modulate those neurological symptoms remain unclear. MET...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398935/ https://www.ncbi.nlm.nih.gov/pubmed/37537664 http://dx.doi.org/10.1186/s12974-023-02861-3 |
_version_ | 1785084139583569920 |
---|---|
author | Proust, Alizé Queval, Christophe J. Harvey, Ruth Adams, Lorin Bennett, Michael Wilkinson, Robert J. |
author_facet | Proust, Alizé Queval, Christophe J. Harvey, Ruth Adams, Lorin Bennett, Michael Wilkinson, Robert J. |
author_sort | Proust, Alizé |
collection | PubMed |
description | BACKGROUND: Although mainly causing a respiratory syndrome, numerous neurological symptoms have been identified following of SARS-CoV-2 infection. However, how the virus affects the brain and how the mutations carried by the different variants modulate those neurological symptoms remain unclear. METHODS: We used primary human pericytes, foetal astrocytes, endothelial cells and a microglial cell line to investigate the effect of several SARS-CoV-2 variants of concern or interest on their functional activities. Cells and a 3D blood–brain barrier model were infected with the wild-type form of SARS-CoV-2, Alpha, Beta, Delta, Eta, or Omicron (BA.1) variants at various MOI. Cells and supernatant were used to evaluate cell susceptibility to the virus using a microscopic assay as well as effects of infection on (i) cell metabolic activity using a colorimetric MTS assay; (ii) viral cytopathogenicity using the xCELLigence system; (iii) extracellular glutamate concentration by fluorometric assay; and (iv) modulation of blood–brain barrier permeability. RESULTS: We demonstrate that productive infection of brain cells is SARS-CoV-2 variant dependent and that all the variants induce stress to CNS cells. The wild-type virus was cytopathic to all cell types except astrocytes, whilst Alpha and Beta variants were only cytopathic for pericytes, and the Omicron variant cytopathic for endothelial cells and pericytes. Lastly wild-type virus increases blood–brain barrier permeability and all variants, except Beta, modulate extracellular glutamate concentration, which can lead to excitotoxicity or altered neurotransmission. CONCLUSIONS: These results suggest that SARS-CoV-2 is neurotropic, with deleterious consequences for the blood–brain barrier integrity and central nervous system cells, which could underlie neurological disorders following SARS-CoV-2 infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02861-3. |
format | Online Article Text |
id | pubmed-10398935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103989352023-08-04 Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions Proust, Alizé Queval, Christophe J. Harvey, Ruth Adams, Lorin Bennett, Michael Wilkinson, Robert J. J Neuroinflammation Research BACKGROUND: Although mainly causing a respiratory syndrome, numerous neurological symptoms have been identified following of SARS-CoV-2 infection. However, how the virus affects the brain and how the mutations carried by the different variants modulate those neurological symptoms remain unclear. METHODS: We used primary human pericytes, foetal astrocytes, endothelial cells and a microglial cell line to investigate the effect of several SARS-CoV-2 variants of concern or interest on their functional activities. Cells and a 3D blood–brain barrier model were infected with the wild-type form of SARS-CoV-2, Alpha, Beta, Delta, Eta, or Omicron (BA.1) variants at various MOI. Cells and supernatant were used to evaluate cell susceptibility to the virus using a microscopic assay as well as effects of infection on (i) cell metabolic activity using a colorimetric MTS assay; (ii) viral cytopathogenicity using the xCELLigence system; (iii) extracellular glutamate concentration by fluorometric assay; and (iv) modulation of blood–brain barrier permeability. RESULTS: We demonstrate that productive infection of brain cells is SARS-CoV-2 variant dependent and that all the variants induce stress to CNS cells. The wild-type virus was cytopathic to all cell types except astrocytes, whilst Alpha and Beta variants were only cytopathic for pericytes, and the Omicron variant cytopathic for endothelial cells and pericytes. Lastly wild-type virus increases blood–brain barrier permeability and all variants, except Beta, modulate extracellular glutamate concentration, which can lead to excitotoxicity or altered neurotransmission. CONCLUSIONS: These results suggest that SARS-CoV-2 is neurotropic, with deleterious consequences for the blood–brain barrier integrity and central nervous system cells, which could underlie neurological disorders following SARS-CoV-2 infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02861-3. BioMed Central 2023-08-03 /pmc/articles/PMC10398935/ /pubmed/37537664 http://dx.doi.org/10.1186/s12974-023-02861-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Proust, Alizé Queval, Christophe J. Harvey, Ruth Adams, Lorin Bennett, Michael Wilkinson, Robert J. Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions |
title | Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions |
title_full | Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions |
title_fullStr | Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions |
title_full_unstemmed | Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions |
title_short | Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions |
title_sort | differential effects of sars-cov-2 variants on central nervous system cells and blood–brain barrier functions |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398935/ https://www.ncbi.nlm.nih.gov/pubmed/37537664 http://dx.doi.org/10.1186/s12974-023-02861-3 |
work_keys_str_mv | AT proustalize differentialeffectsofsarscov2variantsoncentralnervoussystemcellsandbloodbrainbarrierfunctions AT quevalchristophej differentialeffectsofsarscov2variantsoncentralnervoussystemcellsandbloodbrainbarrierfunctions AT harveyruth differentialeffectsofsarscov2variantsoncentralnervoussystemcellsandbloodbrainbarrierfunctions AT adamslorin differentialeffectsofsarscov2variantsoncentralnervoussystemcellsandbloodbrainbarrierfunctions AT bennettmichael differentialeffectsofsarscov2variantsoncentralnervoussystemcellsandbloodbrainbarrierfunctions AT wilkinsonrobertj differentialeffectsofsarscov2variantsoncentralnervoussystemcellsandbloodbrainbarrierfunctions |